Back Tuberculosis

AIDS 2016: TB 2016 Demands a Global Commitment to End Tuberculosis

While much of the TB 2016 meeting, held ahead of the 21st International AIDS Conference (AIDS 2016) in Durban, was devoted to the rapidly evolving science in the fight against tuberculosis (TB), the meeting also highlighted the failure of the world, including the international HIV community, to adequately respond to the TB epidemic -- which last year surpassed HIV as the leading infectious cause of death in the world.

alt

Read more:

AIDS 2016: Shortened Regimen for MDR-TB Shows Good Results for Children

The use of a shortened 9-month treatment regimen for multidrug-resistant tuberculosis (MDR-TB), known as the "Bangladesh regimen," was shown to be successful in 83% of children and adolescents diagnosed with rifampicin-resistant TB, researchers reported at the TB 2016 meeting, held ahead of the 21st International AIDS Conference (AIDS 2016) this week in Durban. A second study presented at the meeting showed that the antibiotic levofloxacin can be used to treat MDR-TB in children.

alt

Read more:

CROI 2016: Large-Scale Household Tuberculosis Screening Shows Feasibility in PopART Trial

Offering tuberculosis (TB) screening as part of a home-based HIV testing intervention has the potential to identify numerous TB cases that would otherwise have gone undiagnosed, a report from a large community-based study in Zambia shows. The findings, from the PopART study, were reported by Comfort Phiri of Zambart at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) last week in Boston.

alt

Read more:

WHO Recommends New Test and Shorter Treatment for Tuberculosis

The World Health Organization (WHO) this month released updated recommendations for a new test that can diagnose multidrug-resistant tuberculosis (MDR-TB) more rapidly, and a shorter and less expensive antibacterial regimen that can successfully treat resistant TB in 9 to 12 months.

alt

Read more:

CROI 2016: South Africa XDR-TB Epidemic Due to Transmission Rather than Viral Evolution

A study in KwaZulu-Natal, South Africa, evaluating the social networks as well as clinical and genotypic data from individuals with extensively drug resistant tuberculosis (XDR-TB)has concluded that transmission -- in both hospitals and households -- has been the primary driver of the XDR-TB epidemic in the province, according to a presentation at the annual Conference on Retroviruses and Opportunistic Infections (CROI 2016) last week in Boston.

alt

Read more: